by Rajendra Singh MD Professor of Pathology, University of Pennsylvania Co-Founder, PathPresenter In Part 1, I argued that the hard part of pathology AI starts after the model has an answer. A good model is not enough. We need the infrastructure to get the right case to the right model, bring the [...]
The U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to Cleo Skin, Primaa’s AI solution for skin cancer diagnosis, recognizing it as an innovative device: an important milestone in Primaa's U.S. regulatory pathway.Cleo Skin becomes the first AI tool in dermatopathology to hold both CE-IVDR certification and FDA Breakthrough Device Designation.Already used in Europe, [...]
In this episode, Sidney Ocanagil-Tunstall speaks with Jiaqi Lv, PhD candidate at the University of Warwick's Tissue Image Analytics (TIA) Centre, about his journey into computational pathology and the development of KongNet, an award-winning deep learning algorithm for cell detection and classification. Jiaqi shares how his early work on NuClick and PathLAKE led to the development [...]
By Bianca Collings Lumea, a U.S. leader in digital pathology and clinical diagnostic solutions, today announced the integration of Nonagen Bioscience’s Oncuria® suite of bladder cancer tests into Lumea’s comprehensive digital diagnostics platform. This partnership equips urologists and clinical teams with seamlessly accessible, high-precision, non-invasive diagnostic tools directly within their established reporting and testing workflows. [...]
by Rajendra Singh MD Professor of Pathology, University of Pennsylvania Co-Founder, PathPresenter Most of the conversation about AI in pathology is still about the models. Which algorithm detects cancer best, which foundation model was trained on the most slides, and which biomarker or mutation can now be predicted from an H&E. These [...]
Expands Agilent’s pathology portfolio and establishes a platform for scientific intelligence in tissue-based precision medicine Strengthens Agilent’s ability to support customers across clinical diagnostics, biopharma and life-sciences research Agilent Technologies Inc. today announced the successful completion of its previously announced acquisition of Proscia®, a leading provider of digital-pathology software for clinical and life-sciences customers. Under [...]
Behind every strong lab, a team that makes the difference. Spending time on site with MLD showed once again how much a strong partnership shapes the way elea works in the lab. Parin Shah, Neil Gadhia and Robert Stewart welcomed the elea team, offered their trust and brought the sharp questions that keep things moving. Juan [...]
With more than 280 consultant pathologists supporting over 90 NHS Trusts, Source BioScience expects to scan more than one million slides this year. Its digitally integrated workflow delivers an average turnaround time of 1.8 days. This case study from Indica Labs explores how HALO AP® supports Source BioScience’s digital integration model, helping coordinate outsourced cases, expand [...]
Techcyte, developer of Fusion, the enterprise digital pathology platform, today announced a collaboration with Aignostics, a leading artificial intelligence company that develops AI-powered tissue analysis products, to connect their technologies into a single automated research workflow. The integration, currently in advanced development, aims to link Techcyte Fusion® AP, using Aignostics’ AI-powered H&E spatial profiling product (“HETA”), [...]
The latest generation of cancer therapies, including antibody-drug conjugates and bispecifics, is testing the limits of biomarker strategies, and success depends on far more than target expression at the cell. The tumor microenvironment, spatial biology and cancer cells morphological changes matter just as much, sometimes shaping how a therapy or payload actually works. Yet these signals [...]
